ABT CIK: 1800

Abbott Laboratories

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
10.5
FY22:
9.58
FY23:
7.26
FY24:
8.56
FY25:
9.57
Change from FY21 to FY25
billions USD
FY21:
−2.01
FY22:
−1.74
FY23:
−3.13
FY24:
−2.34
FY25:
−2.42
Change from FY21 to FY25
billions USD
FY21:
−5.49
FY22:
−7.64
FY23:
−7.09
FY24:
−5.40
FY25:
−6.31
billions USD
FY21:
2.96
FY22:
0.08
FY23:
−2.99
FY24:
0.72
FY25:
0.91
(positive)
Change from FY21 to FY25
billions USD
FY21:
8.65
FY22:
7.80
FY23:
5.06
FY24:
6.35
FY25:
7.40

All amounts in billions USD Data source:SEC EDGAR